What is the clinical evidence from this study?

Study design: Letter. Population: First-Onset ST-Elevation Myocardial Infarction (STEMI) (n=8779). Intervention: Stress hyperglycemia vs. No stress hyperglycemia. Primary outcome: Mortality.

What question did this study set out to answer?

To assess how patient age alters the relative and absolute prognostic significance of stress hyperglycemia following a first-onset ST-elevation myocardial infarction.

September 14, 2026Journal of Diabetes InvestigationOpen Access

Comment on “Influence of Age on the Development of Stress Hyperglycemia During First‐Onset ST ‐Elevation Myocardial Infarction”

Q: What are the key findings of this study?

Stress hyperglycemia is associated with a higher relative mortality risk in younger patients, though absolute mortality rates are significantly higher in older patients (23.33% at 30 days for age ≥80 vs 1.14% for age <40).

View Full Paper

Ask AI

Bookmark

Key result

Stress hyperglycemia links to higher relative mortality in younger patients despite greater absolute mortality in older adults.

n=8,779

Authors

DADr Muhammad Mussab AmanDoctors Hospital AIAndaleeb IkramKhyber Teaching Hospital NTNajib Ullah TokhiGomal University

Discussion

Member takes

Implication

Registry study reveals age-dependent mortality associations with stress hyperglycemia in myocardial infarction, indicating high absolute risk despite lower relative hazard in older patients.

Key Points

To assess how patient age alters the relative and absolute prognostic significance of stress hyperglycemia following a first-onset ST-elevation myocardial infarction.
Analyzed national registry data comprising 8,779 patients presenting with first-onset ST-elevation myocardial infarction without prior diabetes.
Evaluated the stress hyperglycemia ratio alongside age-stratified 30-day and 10-year mortality rates.
Assessed in-hospital medication disparities, including beta-blockers, ACE-inhibitors/angiotensin receptor blockers, lipid-lowering agents, and dual antiplatelet therapy.
Absolute mortality significantly increased from 1.14% at 30 days and 3.43% at 10 years in patients aged <40 years to 23.33% and 58.40%, respectively, in patients aged ≥80 years, despite hazard ratios for stress hyperglycemia declining with advancing age.
Patients presenting with stress hyperglycemia had lower rates of receiving guideline-directed therapies during hospital admission, including beta-blockers, ACE-inhibitors/angiotensin receptor blockers, lipid-lowering agents, and dual antiplatelet therapy.

PICO

Population

8,779 patients with first-onset ST-elevation myocardial infarction and no prior history of diabetes from a national registry study.

Exposure / Comparator

Stress hyperglycemia vs No stress hyperglycemia

Primary Outcome

Mortality

Limitations

Published mortality models do not account for disparities in evidence-based treatments (e.g., beta-blockers, ACE inhibitors) between patients with and without stress hyperglycemia.
It remains unclear whether younger patients with stress hyperglycemia would benefit from specific glucose-lowering treatment regimens.

Cite This Study

Aman et al. (2026) conducted a letter in First-Onset ST-Elevation Myocardial Infarction (STEMI) (n=8,779). Stress hyperglycemia vs. No stress hyperglycemia was evaluated on Mortality. Stress hyperglycemia is associated with a higher relative mortality risk in younger patients, though absolute mortality rates are significantly higher in older patients (23.33% at 30 days for age ≥80 vs 1.14% for age <40).

synapsesocial.com/papers/6aa7b12f79e9260bc85aad52 https://doi.org/10.1111/jdi.70443

View Full Paper

Ask AI

Bookmark

Implication

Registry study reveals age-dependent mortality associations with stress hyperglycemia in myocardial infarction, indicating high absolute risk despite lower relative hazard in older patients.

Comment on “Influence of Age on the Development of Stress Hyperglycemia During First‐Onset ST ‐Elevation Myocardial Infarction”

Discussion

Member takes

Implication

Key Points

PICO

Limitations

Cite This Study

Comment on “Influence of Age on the Development of Stress Hyperglycemia During First‐Onset ST ‐Elevation Myocardial Infarction”

Discussion

Member takes

Implication

Key Points

PICO

Limitations

Cite This Study

Also Consider

Also Consider